Listed biotech firm set to raise £6.5m

MANCHESTER biotech company Epistem Holdings is to push ahead with its bid to secure equity funding of £6.5m to broaden the portfolio of its Genedrive tests, developed to fight infectious diseases such as TB across the globe.

The listed company, as a result, has agreed to a request from selected shareholders and potential investors to extend the maturity date of an $8m bond.

The company has announced that it has recently received a non-binding investment committee approved commitment from Calculus Capital, a U... For the full story register now for free or login below...